Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by de HAAN, L. Articles by LINSZEN, D. Search for Related Content PubMed Citation Articles by de HAAN, L. Articles by LINSZEN, D. Neurotransmitters Atypical Neuroleptics Conventional Neuroleptics

Comfort, Self-Confidence, Safety, and Dopamine D₂ Receptor Occupancy by Antipsychotics

To the Editor: Antipsychotics are thought to influence the subjective well-being of patients, depending on the occupancy of these receptors (1–3). Drug-induced dysphoria is related to quality of life and medication compliance. It may also be a sensitive marker for too high dopamine D₂ receptor occupancy caused by conventional and newer-generation antipsychotics (1–3). However, adverse mental effects of antipsychotics are difficult to differentiate from primarily negative symptoms and depressive symptoms, and little is known about which aspects of subjective experience are most strongly related to D₂ receptor occupancy.

We sought to identify which aspects of subjective well-being are most strongly related to D₂ receptor occupancy by conventional and newer-generation antipsychotics.

An analysis was performed on the combined data of two previous studies (2, 3). These studies were approved by the ethics committee of the Academic Medical Centre, Amsterdam, the Netherlands. The subjects, 50 patients, 48 with recent-onset schizophrenia and two with schizoaffective disorder, were diagnosed according to DSM-IV criteria; 45 were men, and the mean age was 22.1 years (SD=2.5).

The patients’ subjective experience was measured with the Subjective Well-Being Under Neuroleptics Scale (4) after a stable dosing period of at least 6 weeks of olanzapine (N=27, mean=11.2 mg/day, SD=4.5), risperidone (N=12, mean=3.6 mg/day, SD=1.1), or haloperidol (N=11, 2.5 mg/day). Higher scores on the Subjective Well-Being Under Neuroleptics Scale imply more favorable subjective well-being. To determine the levels of striatal D₂ receptor occupancy, [¹²³I]IBZM single photon emission computed tomography imaging was performed. Specifications of comparison group, imaging procedures, and data analyses have been described elsewhere (1, 2).

All 38 items from the Subjective Well-Being Under Neuroleptics Scale were negatively correlated with D₂ receptor occupancy, with 28 items reaching statistical significance (Spearman’s correlation, two-tailed). The highest correlations were found for five items on the Subjective Well-Being Under Neuroleptics Scale that could be described as "feeling comfortable, self-confident, and safe": "I feel very comfortable with my body" (r_s=–0.448, df=49, p=0.001), "My body is a burden to me" (r_s=–0.433, df=49, p=0.002), "I am full of confidence, everything will be all right" (r_s=–0.429, df=49, p=0.002), "I do what I want to do and know how to assert myself" (r_s=–0.419, df=49, p=0.002), and "I feel safe and secure" (r_s=–0.382, df=49, p=0.006).

Negative subjective experiences are related to D₂ receptor occupancy by conventional and newer generation antipsychotics. Monitoring feelings of comfort, self-confidence, and safety may guide clinicians and researchers to find optimal D₂ receptor occupancy. To test this hypothesis, however, more research is needed.

References

1. Kapur SJ, Zipursky R, Jones C, Remington G, Houle S: Relationship between dopamine D₂ occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 2000; 157:514–520[Abstract/Free Full Text]
2. de Haan L, Lavalaye J, Linszen D, Dingemans PMAJ, Booij J: Subjective experience and striatal dopamine D₂ receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry 2000; 157:1019–1020[Abstract/Free Full Text]
3. de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PMAJ, Linszen D: Subjective experience and D₂ receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 2003; 160:303–309[Abstract/Free Full Text]
4. de Haan L, Weisfelt M, Dingemans PMAJ, Linszen DH, Wouters L: Psychometric properties of the Subjective Well-Being Under Neuroleptics Scale (SWN) and the Subjective Deficit Syndrome Scale (SDSS). Psychopharmacology 2002; 162:24–28[CrossRef][Medline]

Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by de HAAN, L. Articles by LINSZEN, D. Search for Related Content PubMed Citation Articles by de HAAN, L. Articles by LINSZEN, D. Neurotransmitters Atypical Neuroleptics Conventional Neuroleptics

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us